| Literature DB >> 26293657 |
Johanne Jeppesen Lomholt1, Mikael Thastum2, Anne Estmann Christensen3, Anne Leegaard4, Troels Herlin5.
Abstract
BACKGROUND: Pain is still a part of everyday living for several children with juvenile idiopathic arthritis (JIA) despite improvement in treatment. Psychological interventions may contribute to diminish pain complaints and improve well-being in children with JIA. Only few studies have investigated the efficacy of psychological therapy in children with arthritis and with mixed results. The aim of the study was to evaluate the feasibility and preliminary efficacy of a cognitive behavioral therapy group intervention for children with JIA and their parents.Entities:
Mesh:
Year: 2015 PMID: 26293657 PMCID: PMC4546223 DOI: 10.1186/s12969-015-0032-x
Source DB: PubMed Journal: Pediatr Rheumatol Online J ISSN: 1546-0096 Impact factor: 3.054
Fig. 1A flow diagram of the study
Demographic data about feasibility of the intervention
| Credibility of the intervention (range 1–5): | Mean ( |
| 1) At this point, how relevant do you think this intervention was to you? | 3.94 (0.70) |
| 2) At this point, how confident are you that this intervention will be rewarding for you? | 4.08 (0.75) |
| 3) At this point, how successful do you think this intervention will be in helping other children with arthritis to manage their disease and pain more effectively? | 4.19 (0.75) |
| 4) At this point, how successful do you think this intervention will be in helping other parents with children with arthritis manage their child’s disease and pain more effectively? | 4.03 (0.76) |
| 5) At this point, would you recommend to others that they should participate in this intervention? | 4.47 (0.67) |
| Total score | 4.14 (0.51) |
| Satisfaction with the intervention | Mean ( |
| ESQ parent’s-version (range −12-12) | 9.56 (1.56) |
| ESQ children’s-version (range −10-10) | 7.76 (2.36) |
Demographic characteristics of the study population
| Treatment condition (n = 9) | Waitlist Condition (n = 10) | Group differences |
| |
|---|---|---|---|---|
| Age (year): mean ( | 11.4 (2.0) | 12.0 (1.4) |
| 0.41 |
| Gender (female) | 8 (89 %) | 7 (70 %) |
| 0.66 |
| JIA categories: |
| 0.34 | ||
| Systemic arthritis | 1 (11 %) | 1 (10 %) | ||
| Oligoarthritis persistent | 2 (22 %) | 4 (40 %) | ||
| Oligoarthritis extended | 2 (22 %) | 0 (0 %) | ||
| Polyarthritis (RF-negative) | 2 (22 %) | 3 (30 %) | ||
| Polyarthritis (RF-positive) | 0 (0 %) | 1 (10 %) | ||
| Psoriatic arthritis | 2 (22 %) | 0 (0 %) | ||
| Enthesitis-related arthritis | 0 (0 %) | 1 (10 %) | ||
| Time from onset to diagnosis (year): mean( | 0.7 (0.8) | 0.8 (0.7) | Z = −0.53 | 0.60 |
| Disease duration(year): mean( | 5.1 (4.0) | 7.6 (4.0) |
| 0.14 |
| Current use of medication: | ||||
| Methotrexate use | 4 (44 %) | 3 (30 %) |
| 0.52 |
| Etanercept use | 3 (33 %) | 4 (40 %) |
| 0.76 |
| Treatment time with methotrexate (year): mean( | 0.9 (1.4) | 0.9 (1.3) | Z = −0.05 | 0.97 |
| Treatment time with etanercept (year): mean( | 0.5 (1.0) | 1.4 (2.9) | Z = −2.01 | 0.91 |
a Time from onset of symptoms to time of JIA diagnosis
b Time from onset of symptoms to the participation in the study
Differences in post-scores in primary outcomes between the condition receiving immediately treatment (n = 9) and the waitlist (n = 10)
| Dependent variable | Pre-score | Post-score | Comparison between conditions | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Measure | Range | Mean (SD) | Unadjusted mean (SD) | Adjusted mean (SE)a | F-value |
| Partial Eta2 | |||
| Treatment | Waitlist | Treatment | Waitlist | Treatment | Waitlist | |||||
|
| ||||||||||
| Pain intensity | 0–10 | 3.06 (2.69) | 2.70 (1.57) | 4.08 (2.66) | 2.70 (1.77) | 3.50 (0.73) | 3.23 (0.69) | 0.06 | 0.81 | 0.004 |
| Functional disability | 0–60 | 11.37 (3.98) | 9.78 (7.91) | 11.67 (9.51) | 9.20 (9.67) | 9.78 (3.12) | 10.90 (3.01) | 0.06 | 0.81 | 0.004 |
|
| ||||||||||
| Total (generic) | 0–100 | 62.77 (14.28) | 75.95 (14.77) | 69.85 (14.05) | 72.84 (15.39) | 77.63 (4.32) | 68.62 (4.03) | 1.96 | 0.18 | 0.12 |
| Treatment | 0–100 | 73.02 (27.38) | 78.73 (15.81) | 75.79 (16.92) | 80.00 (13.59) | 77.99 (4.84) | 78.02 (4.55) | 0.001 | 0.98 | 0.0001 |
| Worry | 0–100 | 70.37 (30.93) | 75.00 (19.24) | 83.33 (15.02) | 77.50 (18.45) | 88.37 (5.12) | 72.96 (4.82) | 4.22 | 0.06 | 0.22 |
| Communication | 0–100 | 68.52 (28.19) | 61.11 (25.15) | 81.48 (14.89) | 63.33 (30.48) | 85.70 (8.93) | 59.53 (8.44) | 3.99 | 0.06 | 0.21 |
a Mean and standard error adjusted for covariates (pre-score and differences in disease activity)
Differences in post-scores in secondary outcomes between the condition receiving immediately treatment (n = 9) and the waitlist (n = 10)
| Dependent variable | Pre-score | Post-score | Comparison between conditions | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Measure | Range | Mean (SD) | Unadjusted mean (SD) | Adjusted mean (SE)a | F-value |
| Partial Eta2 | |||
| Treatment | Waitlist | Treatment | Waitlist | Treatment | Waitlist | |||||
|
| ||||||||||
| Catastrophizing | 1–5 | 2.24 (0.91) | 2.18 (0.57) | 1.71 (0.50) | 2.02 (0.87) | 1.61 (0.27) | 2.11 (0.25) | 1.67 | 0.21 | 0.10 |
| Control beliefs | 1–3 | 1.93 (0.32) | 1.76 (0.40) | 2.22 (0.41) | 1.73 (0.41) | 2.22 (0.16) | 1.73 (0.15) | 4.27 | 0.06 | 0.22 |
| Harm beliefs | 1–3 | 2.29 (0.35) | 2.05 (0.43) | 2.10 (0.29) | 2.03 (0.42) | 2.01 (0.12) | 2.11 (0.11) | 0.29 | 0.60 | 0.02 |
| Disability beliefs | 1–3 | 2.15 (0.25) | 1.68 (0.45) | 1.93 (0.40) | 1.86 (0.44) | 1.76 (0.15) | 2.00 (0.14) | 1.06 | 0.32 | 0.07 |
| Self-efficacy: Symptom | 1–5 | 2.83 (1.06) | 2.58 (0.86) | 2.97 (0.91) | 2.13 (0.82) | 2.95 (0.34) | 2.14 (0.32) | 3.21 | 0.09 | 0.18 |
| Self-efficacy: Activity | 1–5 | 2.72 (1.05) | 2.67 (1.22) | 3.36 (0.53) | 2.63 (1.16) | 3.40 (0.32) | 2.59 (0.30) | 3.04 | 0.10 | 0.17 |
| Self-efficacy: Emotion | 1–5 | 3.07 (1.22) | 2.48 (1.18) | 3.37 (1.14) | 2.27 (0.95) | 3.25 (0.31) | 2.38 (0.29) | 3.75 | 0.07 | 0.20 |
aMean and standard error adjusted for covariates (pre-score and differences in disease activity)